Home
STAY INFORMED
Subscribe to our monthly newsletter.
Your email address will never be disclosed to any third party.
Read our privacy notice.

     

News

Post your news
Filter reactor - All-in-one solution For reaction, purification, crystallization, filtration and (pre)drying
Filter reactor - All-in-one solution
For reaction, purification, crystallization, filtration and (pre)drying Chemical Reactors and process equipment require dedicated solutions because of the type of chemistry, processes, environment and operating conditions involved. The proven engineering - and manufacturing expertise by Büchi Glas Uster lead to perfect solutions for R&D and production scale. Büchi now introduces an all-in-one solution for reaction, purification, crystallization, filtration and (pre) drying! The filter reactor! Büchi Filter-Reactors are used for: • Solid phase reactions • Building blocks and derivatives synthesis • Oligonucleotide chemistry • Liquid phase reactions The filter reactor is a modular, compact and mobile solution and can be built in different materials, also in combinations of materials (glass & Hastelloy). In addition: • Different agitators and motors are available • A double jacketed vessel if required • Different mesh sizes • Equipped with a lift for easily lowering and lifting the vessel • Automated filter
17-08-2018  |  005x  |  Product news  | 
Human Cardiomyocytes Human Cardiomyocytes | Creative Bioarray
Human Cardiomyocytes
Human Cardiomyocytes | Creative Bioarray Cardiomyocytes are derived from the whole heart (of a single donor) that has been dissociated into single cells and cultured using differential adhesion. These cells are characterized by immunostaining of cardiac sarcomeric actin, myosin heavy chain and other cardiac markers. Cardiomyocytes may be used in various in vitro or in vivo studies; transplantation into normal or diseased systems; cardiac toxicology studies; or cardiovascular developmental studies.
15-08-2018  |  005x  |  Product news  | 
Hepatoma Cells Hepatoma Cells | Creative Bioarray
Hepatoma Cells
Hepatoma Cells | Creative Bioarray Established from the tumor tissue of an 8-year-old black boy in 1976.The cells contain a 2.3 kb integrated hepatitis B virus genome fragment. However there is currently no evidence that this cell line produces infectious Hepatitis B virus. Cells were described to produce a variety of proteins, e.g. alpha-fetoprotein, albumin, transferrin, alpha2-macroglobulin, alpha1-antitrypsin, haptoglobin and others.
15-08-2018  |  014x  |  Wiki item  | 
Primary fibroblasts Primary fibroblasts | Creative Bioarray
Primary fibroblasts
Primary fibroblasts | Creative Bioarray Fibroblasts, the most common mammalian connective tissue cells, are specialized for the secretion of collagenous extracellular matrix and are jointly responsible for the architectural framework of the body. A fibroblast cell plays a critical role in wound healing. When a tissue is injured, the fibroblasts nearby proliferate, migrate into the wound, and produce large amounts of collagenous matrix, which helps to isolate and repair the damaged tissue. Features of Fibroblasts from Creative Bioarray: ☆ Isolated from human healthy and diseased donors, as well as animals such as mouse, rat, and monkey. ☆ High purity, low passage, rigorously characterized, and performance tested. ☆ Available for a variety of research areas including pulmonary, cardiology, dermatology, gastrointestinal, oncology.
15-08-2018  |  016x  |  Wiki item  | 
Cytokines & Growth Factors Cytokines & Growth Factors | Creative Bioarray
Cytokines & Growth Factors
Cytokines & Growth Factors | Creative Bioarray GROa is a member of the a (CXC) family of chemokines. It is produced by monocytes, neutrophils, mast cells, epithelial cells, endothelial cells, keratinocytes and tumor cells. GRO expression is inducible by serum or PDGF and/or by a variety of inflammatory mediators, such as IL-1 and TNF. GROa is a chemoattractant for neutrophils, lymphocytes, monocytes, and epidermal melanocytes. In addition, GROa induces activation of neutrophils and basophils, has angiogenic effects, inhibits erythrocyte invasion and decreases the expression of interstitial collagen. GROa binds to IL-8R-A, IL-8R-B and DARC. Human GROa cDNA encodes a 107 amino acid residue precursor protein containing 34 N-terminal amino acid residues that are cleaved to generate the mature protein. The recombinant maturehuman GROa contains 73 amino acid residues and has an apparent molecular mass of 7.9 kDa.
15-08-2018  |  015x  |  Product news  | 
MEA pharma economy to reach US$38.8bn by 2021
Amsterdam, 15th August 2018: CPhI MEA (Middle East and Africa) launches next month as favourable market conditions are driving increased growth across the Middle East and North Africa (MENA) pharma market – ageing and gentrifying populations, increased healthcare spending, and a modernising supply chain are transforming prospects in the region. Total pharma sales have reached an impressive $32 billion across MENA as a whole – the Middle East accounts for $20.3 billion and North Africa $10.7 billion. The increasingly gentrified populations in Sub-Saharan African countries and the development of sophisticated universal healthcare systems in the Middle East are providing robust growth opportunities. In particular, the finished dosage formulation sector is expanding particularly quickly in the Middle East, with a number of plants being commissioned in the last few years. In the UAE, the government also fast-tracks approval of locally manufactured drugs, which is helping
15-08-2018  |  014x  |  News in brief
Following 6 items
ARCHIVE
AUG
2018
JULY
2018
JUNE
2018
MAY
2018
APR
2018
MAR
2018
FEB
2018
JAN
2018
DEC
2017
NOV
2017
OCT
2017
SEPT
2017
MAXUS MEDIA
LABinsights.net LABinsights.de LABinsights.nl
SIGN UP FOR OUR NEWSLETTER
Newsletter archive
Service and contact
ContactDisclaimerPrivacyAdvertisingControl panel log-in